For the Annual General Meeting of Shareholders to be held in May 2026, 10 director candidates have been nominated. One new director and one resigning director have been decided.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4530","jir_company_name":"Hisamitsu Pharmaceutical Co., Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-04-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4530-20260413-02.pdf","jir_short_summary":"For the Annual General Meeting of Shareholders to be held in May 2026, 10 director candidates have been nominated. One new director and one resigning director have been decided.","jir_summary":"### Regarding the Nomination of Director Candidates\nHisamitsu Pharmaceutical Co., Inc. has decided to nominate all 10 current directors as director candidates at the Annual General Meeting of Shareholders scheduled for May 28, 2026, due to the expiration of their terms. The composition includes one representative director and nine directors. Additionally, Mr. Sakae Yano (currently Senior Executive Officer) will be newly nominated as a director candidate. The representative director will be selected at the Board of Directors meeting following the conclusion of the Annual General Meeting.\n\n### Regarding Resigning Director\nMr. Yuichiro Anzai, the current outside director, is scheduled to resign. As a result, the director changes consist of one new appointment and one resignation. This executive personnel change aims to strengthen the organizational structure while maintaining management continuity.","jir_financial_highlights":"Number of Director Candidates: 10 (Unknown)\nNew Director: 1 (Sakae Yano) (New appointment)\nResigning Director: 1 (Yuichiro Anzai) (Resignation)\nScheduled Date of Annual General Meeting: 2026-05-28 (Unknown)","jir_category":"","jir_hashtags":"#HisamitsuPharmaceutical, #ExecutivePersonnelChanges, #JapaneseStocks","jir_key_figures":"Number of Director Candidates: 10 (1 Representative Director, 9 Directors)\nNew Director: Sakae Yano (currently Senior Executive Officer)\nResigning Director: Yuichiro Anzai (currently Outside Director)","jir_meta_title":"[Hisamitsu Pharmaceutical] Nomination of Director Candidates Ahead of May 2026 Annual General Meeting","jir_meta_description":"Hisamitsu Pharmaceutical Co., Inc. nominates 10 director candidates for the Annual General Meeting of Shareholders to be held in May 2026. One new director and one resigning director have been decided.","jir_og_title":"[Hisamitsu Pharmaceutical] Nomination of Director Candidates Ahead of May 2026 Annual General Meeting","jir_og_description":"Hisamitsu Pharmaceutical announced 10 director candidates for the May 2026 Annual General Meeting, with one new appointment and one resignation in executive personnel changes.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8125,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-40294","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n